Medical Disorders of Pregnancy Flashcards
Define gestational diabetes
any degree of glucose intolerance with onset or first recognition during pregnancy
Pathophysiology of gestational diabetes
Body unable to produce enough insulin to meet needs of pregnancy
- progressive insulin resistance so higher volume of insulin needed
- woman with a borderline pancreatic reserve is unable to respond to the increased insulin requirements, resulting in transient hyperglycaemia
Risk factors for gestational diabetes
BMI > 30 Asian ethnicity Previous gestational diabetes 1st degree relative with diabetes PCOS Previous macrosomic baby
Clinical features of gestational diabetes
Mostly asymptomatic
Polyuria, polydipsia and fatigue
Foetal complications of gestational diabetes
Glucose but not insulin transported across placenta -> foetal hyperinsulinaemia
- Macrosomia – this can cause complications during labour, such as shoulder dystocia, obstructed/delayed labour, and/or higher rates of instrumental deliveries
- Organomegaly -particularly cardiomegaly
- Erythropoiesis -> polycythaemia
- Polyhydramnios
Increased rates of pre-term delivery
Investigations for gestational diabetes
Oral Glucose Tolerance Test
- a fasting plasma glucose is measured, then a 75g glucose drink is given – with a repeat plasma glucose measurement after 2 hours
- Fasting glucose > 5.6mmol/L
- 2hrs postprandial glucose > 7.8mmol/L
When is the OGTT offered
Booking – if previous gestational diabetes.
24 – 28 weeks’ gestation – if risk factors are present or in cases of previous gestational diabetes
Any point during pregnancy – if 2+ glycosuria on one occasion, or 1+ on two occasions
Management of gestational diabetes
Lifestyle advice
- diet and exercise
Medical
- Metformin – suitable in pregnancy and breast feeding.
- Glibenclamide – used if metformin is not tolerated (often due to GI side effects) and insulin has been declined
- Insulin
- Consider starting at diagnosis if the fasting glucose >7.0mmol/L.
- Or introduce later in pregnancy if
- (i) pre meal glucose > 6.0mmol/L
- (ii) post meal glucose >7.5mmol/L
- (iii) fetal AC (abdominal circumference) >95th centile
Delivery with gestational diabetes
Deliver at 37 to 38 weeks if they are on treatment
Delivery (induction of labour or caesarean section) before 40 weeks and 6 days if there is gestational diabetes managed by diet
Postnatal management of gestational diabetes
All anti-diabetic medication should be stopped immediately after delivery - BM taken at discharge to ensure normal levels
Fasting glucose tolerance test 6-13 weeks post-partum
Yearly tests should be offered because of the increased risk of developing diabetes in the future
In subsequent pregnancies, an OGTT should be offered at booking and at 24 – 28 weeks’ gestation
Definitions of anaemia in pregnancy
1st trimester = < 110g/l
2nd/3rd trimester = < 105g/l
Postpartum = < 100g/l
Plasma volume increases disproportionately to RBC -> haemodilution
Risk factors for anaemia in pregnancy
Haemoglobinopathies - thalassaemia - sickle cell disease Increasing maternal age Low socioeconomic status Poor diet Anaemia during previous pregnancy
Causes of anaemia
Microcytic - iron deficiency - thalassaemia - sideroblastic anaemia Normocytic - anaemia of chronic disease - marrow infiltration - haemolytic anaemia - CKD Macrocytic - B12/folate deficiency - alcohol consumption - reticulocytosis - hypothyroidism
Invetigations for anaemia
FBC - hb and MCV Serum ferritin Consider - haemoglobinopathy screening - serum folate - haemoglobin electrophoresis
Management of iron deficiency anaemia
Trial oral iron (100-200mg)
Parental iron infusion is compliance poor or evidence of malabsorption
Management of folate deficiency
Folate supplementation - 5mg once daily increased up to three times daily
Management of beta thalassaemia
Folate supplementation and blood transfusions as required - aim for Hb of 80g/L during pregnancy and 100g/L at delivery
Management of sickle cell disease
Folate supplementation and iron supplementation if lab evidence or iron deficiency
Define antiphospholipid syndrome
Autoimmune condition in which antibodies are targeted against phospholipid-binding proteins
Pathophysiology of antiphospholipid syndrome
In vivo antibodies induce procoagulant state
Obstetric complications due to
- inhibition of trophoblastic function and differentiation
- activation of complement pathways at maternal-foetal interface
- thrombosis of uteroplacental vasculature
Clinical features of antiphospholipid syndrome
Defined by thrombosis formation and/or recurrent pregnancy loss
Other manifestations include
- Livedo reticularis – red/blue/purple reticular pattern on skin of the trunk, arms or legs
- Valvular heart disease – particularly aortic and mitral regurgitation
- Renal impairment – ischaemia in the small vessels of the kidney can result in chronic kidney disease
- Thrombocytopaenia
Investigations of antiphospholipid syndrome
USS doppler for DVT
Anticardiolipin – detects antibodies that bind cardiolipin (a phospholipid)
Lupus anticoagulant – measures the clotting ability of the blood
Anti-B2-glycoprotein I – detects antibodies that binds B2-glycoprotein I (a molecule that binds with cardiolipin)
Management of antiphospholipid syndrome
Anticoagulation - LMWH or warfarin depending on presentation
Why does pregnancy increase risk of VTE
Changes to levels of proteins in clotting cascade - increased fibrinogen and decreased protein S
Become more pronounced as pregnancy progresses - highest risk post-partum
Risk factors for VTE in pregnancy
Pre-existing factors - Thrombophilia (e.g Antiphospholipid syndrome) - Medical co-morbidities (e.g cancer) - Age >35 years - BMI >30 kg/m2 - Parity >3 - Smoking - Varicose veins - Paraplegia Obstetric Factors - Multiple pregnancy - Pre-eclampsia - Caesarean section - Prolonged labour - Stillbirth - Preterm birth - PPH Transient Factors - Any surgical procedure in pregnancy of puerperium - Dehydration (e.g hyperemesis) - Ovarian hyperstimulation syndrome - Admission or immobility - Systemic infection - Long distance travel
Clinical features of VTE
DVT
- unilateral leg pain and swelling
- pyrexia, pitting oedema, tenderness and prominent superficial veins
- left leg most commonly affected
PE
- sudden onset dyspnoea
- pleuritic chest pain, cough and haemoptysis
Investigations for VTE
DVT - compression duplex USS PE - ECG and CXR - definitive diagnosis by CTPA or V/Q scan
Management of VTE in pregnancy
LMWH started immediately
- maintained until - weeks post-partum
Prophylaxis of VTE in pregnancy
Assessed for risk in early pregnancy
- offered thromboprophylaxis if have > risk factors in 1st+2nd trimester, > 3 in 3rd trimester and >2 post-partum
- continue till at least 6 weeks post-partum
10 day course of LMWH post C-section
Define hyperemesis gravidarum
Persistent and severe vomiting during pregnancy
- leads to weight loss, dehydration and electrolyte imbalances
Pathophysiology of hyperemesis gravidarum
Normally starts between 4-7 weeks gestation - reaches peak in 9th week and settles by 20th week
Thought to be due to rapidly increasing levels of beta hCG
- stimulates chemoreceptor trigger zone in brainstem which feeds into vomiting centre
Risk factors for hyperemesis gravidarum
First pregnancy Previous history Raised BMI Multiple pregnancy Hydatidiform mole